Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation
出版年份 2014 全文链接
标题
Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation
作者
关键词
-
出版物
JOURNAL OF INTERNAL MEDICINE
Volume 276, Issue 3, Pages 215-228
出版商
Wiley
发表日期
2014-03-08
DOI
10.1111/joim.12234
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- Circulating p53-Responsive MicroRNAs as Predictive Biomarkers in Heart Failure After Acute Myocardial Infarction
- (2013) Sarah Evans et al. CIRCULATION RESEARCH
- Identifying novel biomarkers for cardiovascular disease risk prediction
- (2013) Y. Ge et al. JOURNAL OF INTERNAL MEDICINE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Judgment Versus Biomarker Prostate Cancer Gene 3: Which Is Best When Determining the Need for Repeat Prostate Biopsy?
- (2013) Bertrand Tombal et al. UROLOGY
- Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
- (2012) Anju Bhardwaj et al. AMERICAN HEART JOURNAL
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The determination and interpretation of the therapeutic index in drug development
- (2012) Patrick Y. Muller et al. NATURE REVIEWS DRUG DISCOVERY
- Next-generation sequencing in the clinic: are we ready?
- (2012) Leslie G. Biesecker et al. NATURE REVIEWS GENETICS
- Tumor markers in prostate cancer I: Blood-based markers
- (2011) Shahrokh F. Shariat et al. ACTA ONCOLOGICA
- Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies
- (2011) Bruce J. Trock et al. BJU INTERNATIONAL
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacoeconomic evaluation of warfarin pharmacogenomics
- (2011) Joyce HS You EXPERT OPINION ON PHARMACOTHERAPY
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Glycogen Storage Diseases: A Brief Review and Update on Clinical Features, Genetic Abnormalities, Pathologic Features, and Treatment
- (2011) John Hicks et al. ULTRASTRUCTURAL PATHOLOGY
- PK–PD modeling of protein drugs: implications in assay development
- (2011) Lorin K Roskos et al. Bioanalysis
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
- (2010) Michael W. Weiner et al. Alzheimers & Dementia
- The role of metabolites and metabolomics in clinically applicable biomarkers of disease
- (2010) Mamas Mamas et al. ARCHIVES OF TOXICOLOGY
- MicroRNAs and Heart Failure Diagnosis
- (2010) David W. Markham et al. CIRCULATION RESEARCH
- Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia
- (2010) Magdalena Nord et al. CNS Neuroscience & Therapeutics
- Towards a knowledge-based Human Protein Atlas
- (2010) Mathias Uhlen et al. NATURE BIOTECHNOLOGY
- Messy biology and the origins of evolutionary innovations
- (2010) Dan S Tawfik Nature Chemical Biology
- A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
- (2010) Jonathan B Singer et al. NATURE GENETICS
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomic biomarkers: new tools in current and future drug therapy
- (2010) Sarah C. Sim et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Genetic basis for idiosyncratic reactions to antiepileptic drugs
- (2009) Diego Franciotta et al. CURRENT OPINION IN NEUROLOGY
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients
- (2009) Elzbieta A Slodkowska et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Protein microarrays: high-throughput tools for proteomics
- (2009) Oda Stoevesandt et al. Expert Review of Proteomics
- How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease
- (2009) V O Puntmann POSTGRADUATE MEDICAL JOURNAL
- Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
- (2009) L. A. Hindorff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetics of Cystic Fibrosis
- (2009) Sherstin Lommatzsch et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- New serological biomarkers of inflammatory bowel disease
- (2008) Xuhang Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development
- (2007) John A. Wagner Annual Review of Pharmacology and Toxicology
- EAU Guidelines on Prostate Cancer
- (2007) Axel Heidenreich et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started